Literature DB >> 23642916

Open repair of intact thoracoabdominal aortic aneurysms in the American College of Surgeons National Surgical Quality Improvement Program.

Rodney P Bensley1, Thomas Curran, Rob Hurks, Ruby C Lo, Mark C Wyers, Allen D Hamdan, Elliot L Chaikof, Marc L Schermerhorn.   

Abstract

OBJECTIVE: Open surgical repair of thoracoabdominal aortic aneurysms (TAAAs) is uncommon. Mortality rates of 20% are reported in studies using national data and are 5% to 8% in single-institution studies. Clinical trials are currently evaluating branched and fenestrated endografts. The purpose of this study is to establish a benchmark for future comparisons with endovascular trials using open repair of TAAAs in the National Surgical Quality Improvement Program (NSQIP) database.
METHODS: We identified all patients undergoing open elective and emergency surgical repair of intact TAAAs in NSQIP (2005 to 2010) using Current Procedural Terminology (American Medical Association, Chicago, Ill) and International Classification of Diseases, 9th Edition codes. We analyzed demographics, comorbidities, 30-day mortality, postoperative complications, and length of stay. Multivariable logistic regression was used to identify predictors of mortality.
RESULTS: We identified 450 patients who underwent open surgical repair (418 elective, 32 emergent) of an intact TAAA. Mean age was 69.4 years, 60.7% were male, and 85.6% were white. Comorbidities included hypertension (87.1%), chronic obstructive pulmonary disease (27.3%), prior stroke or transient ischemic attack (16.7%), diabetes (11.6%), and peripheral vascular disease (9.6%). Thirty-day mortality was 10.0%. Pulmonary complications were the most common: failure to wean from ventilator (39.1%), pneumonia (23.1%), and reintubation (13.8%). Acute renal failure requiring dialysis occurred in 10.7% of patients. Multivariable analysis (odds ratio [95% confidence interval]) showed predictors of mortality were emergent repair (3.3 [1.03-10.83]; P = .04), age >70 years (3.5 [1.03-7.56], P = .001), preoperative dialysis (8.4 [1.90-37.29], P = .005), cardiac complication (2.9 [1.05-8.21], P = .04), and renal complications (8.4 [3.41-20.56], P < .001).
CONCLUSIONS: In this study of NSQIP hospitals, the first to analyze open surgical repair of TAAAs, the 30-day mortality rate of 10.0% is similar to single-institution reports. However, morbidity and mortality after open TAAA repair remain high, confirming the need for less invasive procedures.
Copyright © 2013 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23642916      PMCID: PMC3784637          DOI: 10.1016/j.jvs.2013.03.037

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  13 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Trends in hospital volume and operative mortality for high-risk surgery.

Authors:  Jonathan F Finks; Nicholas H Osborne; John D Birkmeyer
Journal:  N Engl J Med       Date:  2011-06-02       Impact factor: 91.245

3.  Thoracoabdominal aneurysm repair: a 20-year perspective.

Authors:  Mark F Conrad; Robert S Crawford; J Kenneth Davison; Richard P Cambria
Journal:  Ann Thorac Surg       Date:  2007-02       Impact factor: 4.330

4.  Open surgical repair of 2286 thoracoabdominal aortic aneurysms.

Authors:  Joseph S Coselli; John Bozinovski; Scott A LeMaire
Journal:  Ann Thorac Surg       Date:  2007-02       Impact factor: 4.330

5.  The outcome in the United States after thoracoabdominal aortic aneurysm repair, renal artery bypass, and mesenteric revascularization.

Authors:  A E Derrow; J M Seeger; D A Dame; R L Carter; C K Ozaki; T C Flynn; T S Huber
Journal:  J Vasc Surg       Date:  2001-07       Impact factor: 4.268

6.  Thoracoabdominal aneurysm repair: hybrid versus open repair.

Authors:  Rajendra Patel; Mark F Conrad; Vikram Paruchuri; Christopher J Kwolek; Thomas K Chung; Richard P Cambria
Journal:  J Vasc Surg       Date:  2009-07       Impact factor: 4.268

7.  Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program.

Authors:  Mira Shiloach; Stanley K Frencher; Janet E Steeger; Katherine S Rowell; Kristine Bartzokis; Majed G Tomeh; Karen E Richards; Clifford Y Ko; Bruce L Hall
Journal:  J Am Coll Surg       Date:  2009-11-22       Impact factor: 6.113

8.  Nationwide trends and regional/hospital variations in open versus endovascular repair of thoracoabdominal aortic aneurysms.

Authors:  Joshua M Liao; Faisal G Bakaeen; Lorraine D Cornwell; Kiki Simpson; Scott A Lemaire; Joseph S Coselli; Danny Chu
Journal:  J Thorac Cardiovasc Surg       Date:  2012-09       Impact factor: 5.209

9.  Arch and visceral/renal debranching combined with endovascular repair for thoracic and thoracoabdominal aortic aneurysms.

Authors:  Sung Wan Ham; Terry Chong; John Moos; Vincent L Rowe; Robbin G Cohen; Mark J Cunningham; Alison Wilcox; Fred A Weaver
Journal:  J Vasc Surg       Date:  2011-02-21       Impact factor: 4.268

10.  Hybrid debranching with endovascular repair for thoracoabdominal aneurysms: a comparison with open repair.

Authors:  Himanshu J Patel; Gilbert R Upchurch; Jonathan L Eliason; Enrique Criado; John Rectenwald; David M Williams; G Michael Deeb
Journal:  Ann Thorac Surg       Date:  2010-05       Impact factor: 4.330

View more
  2 in total

Review 1.  State-of the-art review on the renal and visceral protection during open thoracoabdominal aortic aneurysm repair.

Authors:  Karl Waked; Marc Schepens
Journal:  J Vis Surg       Date:  2018-02-08

Review 2.  [Endovascular versus conventional vascular surgery - old-fashioned thinking? Part 1: interventions on the aorta].

Authors:  E S Debus; T Kölbel; D Manzoni; C-A Behrendt; F Heidemann; R T Grundmann
Journal:  Chirurg       Date:  2016-03       Impact factor: 0.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.